Novartis AG raised its full-year guidance Wednesday as it reported strong growth of its newer drugs, bolstering its chief executive’s efforts to focus the pharmaceutical giant on higher-value medicines.
The Basel, Switzerland-based company said it now expects core operating income to grow by a high single-digit percentage, up from earlier guidance of a mid-to-high single digit rise. It said it continued to expect sales to increase by a mid-single-digit percentage.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:
Revamping his annual bonus.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
US stocks rally again to record highs as earnings smash expectations — 'Is it different this time?'Better-than-expected earnings unleashed a wave of optimism in the US, sending the S&P 500 to its 'third big high.' Asia and Europe weren't as upbeat. When the “is it different this time?” stories start it is time to het your money out because a crash is around the corner 'earnings smash expectations'. Whose earnings? The 99%ers'?
출처: BusinessInsider - 🏆 729. / 51 더 많은 것을 읽으십시오 »
European shares dip as China policy concerns temper earnings boostEuropean shares pulled back from eight-month highs on Wednesday as worries over ...
출처: Reuters - 🏆 2. / 97 더 많은 것을 읽으십시오 »
Caterpillar is set to report earnings before the bell — here's what the Street expectsCaterpillar is reporting first-quarter earnings before the bell on Wednesday.
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »
Boeing earnings expected before the bell as market looks for 737 Max newsBoeing's first-quarter earnings report is expected before the market opens on Wednesday.
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »